154 related articles for article (PubMed ID: 10801059)
1. The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.
Pelled D; Shogomori H; Futerman AH
J Inherit Metab Dis; 2000 Mar; 23(2):175-84. PubMed ID: 10801059
[TBL] [Abstract][Full Text] [Related]
2. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.
Korkotian E; Schwarz A; Pelled D; Schwarzmann G; Segal M; Futerman AH
J Biol Chem; 1999 Jul; 274(31):21673-8. PubMed ID: 10419477
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
[TBL] [Abstract][Full Text] [Related]
4. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
Prence EM; Chaturvedi P; Newburg DS
J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
Das PK; Murray GJ; Gal AE; Barranger JA
Exp Cell Res; 1987 Feb; 168(2):463-74. PubMed ID: 3803450
[TBL] [Abstract][Full Text] [Related]
6. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
Newburg DS; Shea TB; Yatziv S; Raghavan SS; McCluer RH
Exp Mol Pathol; 1988 Jun; 48(3):317-23. PubMed ID: 3371456
[TBL] [Abstract][Full Text] [Related]
7. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
Hamler R; Brignol N; Clark SW; Morrison S; Dungan LB; Chang HH; Khanna R; Frascella M; Valenzano KJ; Benjamin ER; Boyd RE
Anal Chem; 2017 Aug; 89(16):8288-8295. PubMed ID: 28686011
[TBL] [Abstract][Full Text] [Related]
8. Klotho-Related Protein KLrP: Structure and Functions.
Hayashi Y; Ito M
Vitam Horm; 2016; 101():1-16. PubMed ID: 27125736
[TBL] [Abstract][Full Text] [Related]
9. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
[TBL] [Abstract][Full Text] [Related]
10. Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels.
Xu YH; Reboulet R; Quinn B; Huelsken J; Witte D; Grabowski GA
Mol Genet Metab; 2008 Jun; 94(2):190-203. PubMed ID: 18346921
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.
Trajkovic-Bodennec S; Bodennec J; Futerman AH
Blood Cells Mol Dis; 2004; 33(1):77-82. PubMed ID: 15223015
[TBL] [Abstract][Full Text] [Related]
12. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model.
Lamghari M; Barrias CC; Sá Miranda C; Barbosa MA
Blood Cells Mol Dis; 2005; 35(3):348-54. PubMed ID: 16125984
[TBL] [Abstract][Full Text] [Related]
13. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
Pastores GM
Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
[TBL] [Abstract][Full Text] [Related]
14. Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.
Meivar-Levy I; Horowitz M; Futerman AH
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):377-82. PubMed ID: 7980395
[TBL] [Abstract][Full Text] [Related]
15. The
Dai GY; Yin J; Li KE; Chen DK; Liu Z; Bi FC; Rong C; Yao N
J Biol Chem; 2020 Jan; 295(3):717-728. PubMed ID: 31819005
[TBL] [Abstract][Full Text] [Related]
16. The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
Yamaguchi Y; Sasagasako N; Goto I; Kobayashi T
J Biochem; 1994 Sep; 116(3):704-10. PubMed ID: 7852294
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramides stimulate mitogenesis in aged murine epidermis.
Marchell NL; Uchida Y; Brown BE; Elias PM; Holleran WM
J Invest Dermatol; 1998 Apr; 110(4):383-7. PubMed ID: 9540979
[TBL] [Abstract][Full Text] [Related]
18. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha.
Kacher Y; Golan A; Pewzner-Jung Y; Futerman AH
Blood Cells Mol Dis; 2007; 39(1):124-9. PubMed ID: 17482853
[TBL] [Abstract][Full Text] [Related]
19. Glucosylceramide modulates endolysosomal pH in Gaucher disease.
Sillence DJ
Mol Genet Metab; 2013 Jun; 109(2):194-200. PubMed ID: 23628459
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramides stimulate murine epidermal hyperproliferation.
Marsh NL; Elias PM; Holleran WM
J Clin Invest; 1995 Jun; 95(6):2903-9. PubMed ID: 7769132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
